Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Voyageur Pharmaceuticals Ltd
VYYRF
Primary Symbol:
V.VM
Healthcare
Drug Manufacturers - Specialty & Generic
Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX...
, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Company Website
Add To Watchlist
Bullboard (TSXV:VM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(58)
•••
WarrantOfficer
X
View Profile
View Bullboard History
Comment by
WarrantOfficer
on Jun 12, 2024 8:22am
RE:RE:Brent seems pretty upbeat on this one.
Indeed an industry changer. One of my main concerns is Voyageurs consistent lack of expedited forward traction. An international corp will step in with a bank full of dollars while Voyageur fumbles
...more
(58)
•••
WarrantOfficer
X
View Profile
View Bullboard History
Comment by
WarrantOfficer
on Jun 12, 2024 8:12am
RE:RE:RE:RE:Brent seems pretty upbeat on this one.
Personally, this is not my first choice as a financing avenue. Selling part of the company equates to reduced profits.
Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million
posted Nov 21, 2024 9:00am by
Innocan Pharma Corp
-
|
"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more
(76)
•••
postie1
X
View Profile
View Bullboard History
Comment by
postie1
on Jun 11, 2024 7:52pm
RE:RE:RE:Brent seems pretty upbeat on this one.
Who knows but a bigger company could provide financing for a chunk of VM?
(76)
•••
postie1
X
View Profile
View Bullboard History
Comment by
postie1
on Jun 11, 2024 7:24pm
RE:RE:Brent seems pretty upbeat on this one.
If this molecule can carry other drugs more affectively, then how much will it be worth to a bigger company? One thing VM might have going for it in case of a lowball offer is us. A lot of shares are
...more
(77)
•••
biggdogg
X
View Profile
View Bullboard History
Comment by
biggdogg
on Jun 11, 2024 6:34pm
RE:Brent seems pretty upbeat on this one.
Its a billion$ molecule, He is at MArs conference, according to LinkedIn, rubbing shoulders with Big Pharma, The folks at Mars are in for an awakening, this molecule is revolutionary.
(53)
•••
whitenorth72
X
View Profile
View Bullboard History
Post by
whitenorth72
on Jun 11, 2024 4:38pm
Brent seems pretty upbeat on this one.
https://youtu.be/useFs_BqpGA
(53)
•••
whitenorth72
X
View Profile
View Bullboard History
Post by
whitenorth72
on Jun 11, 2024 12:01pm
Gd@C60, Bi@C60, and I@C60
If successful these new drugs will change everything. I understand why the pause on FDA. Why throw money down on existing generics through a ridiculous and expensive approval process with the FDA when
...more
(77)
•••
biggdogg
X
View Profile
View Bullboard History
Post by
biggdogg
on Jun 11, 2024 10:38am
New molecules
If Rain Cage is successful making gadolinium, Bismuth endofullerene, this company is going to get swallowed up. Based on the studies, like this, "Gain of a 500-fold sensitivity on an intravital
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jun 11, 2024 8:30am
New Press Release - Testing to Begin of Radiology Endohedral Fullerenes, a Milestone in Nanotechnology & Drug Development
(TheNewswire)Calgary, Alberta, Canada, June 11, 2024 – TheNewswire – Voyageur Pharmaceuticals Ltd. (TSX.V: VM) (USA: VYYRF) ("Voyageur" or the "Company") announces that in an innovative endeavor, Voyageur and Rain Cage Carbon Inc. ("Rain Cage") are following up on the first commercial creation of...
read article.
(76)
•••
postie1
X
View Profile
View Bullboard History
Comment by
postie1
on Jun 10, 2024 2:02pm
RE:Almost a million for sale at .08
720,000 divided by DA of 79,000 is less than 10 days. IMO If VM was a village we all know who that "one" would be.
(88)
•••
oldtrouf
X
View Profile
View Bullboard History
Post by
oldtrouf
on Jun 10, 2024 1:10pm
Almost a million for sale at .08
6 months of volume for sale at .08. Turn out the lights. #NoSales #NoHope #VMGoingToZero
(2126)
•••
lscfa
X
View Profile
View Bullboard History
Post by
lscfa
on Jun 07, 2024 5:43pm
2000 ton permit status?
What happened to this? This high grade material could be a low cost source for end products. https://stockhouse.com/news/press-releases/2022/09/22/voyageur-pharmaceuticals-ltd-submits
...more
(76)
•••
postie1
X
View Profile
View Bullboard History
Comment by
postie1
on Jun 07, 2024 3:14pm
RE:RE:RE:RE:Endohedral Fullerene $167,000,000/gram
Well, I guess the fact that it was BMO who sold down on small volume and it BMO that ran it back up on bigger volume(over 300,000 at this moment) kind of backs you up. Shake that tree is what the pros
...more
(76)
•••
postie1
X
View Profile
View Bullboard History
Comment by
postie1
on Jun 07, 2024 1:15pm
RE:RE:RE:Endohedral Fullerene $167,000,000/gram
Not going to disagree with you on that.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover Options Trading Strategies to Minimize your Tax Burden